PTEN and schizophrenia: Although further details remain to be elucidated, our results at minimum suggest that (i) SLC6A20A is a novel regulator of brain glycine and proline homeostasis; (ii) SLC6A20A could underlie abnormal synaptic functions and behaviors; (iii) Slc6a20a expression can be altered by defects in brain disease‐related proteins, such as PTEN; and (iv) SLC6A20A could be a potential target for intervention in brain disorders associated with lowered NMDAR function, including schizophrenia and ASD (Olney et al, 1999; Lee et al, 2015).